A pharmaceutical company and health care venture investor are forming BlueRock Therapeutics, a biotechnology enterprise to design regenerative medicine treatments with stem cells. . . . → Read More: Stem Cell Therapy Company Formed, Staked to $225M
|
|||||
A pharmaceutical company and health care venture investor are forming BlueRock Therapeutics, a biotechnology enterprise to design regenerative medicine treatments with stem cells. . . . → Read More: Stem Cell Therapy Company Formed, Staked to $225M An individual with lung cancer tumors that spread from the colon had the tumors reduced in size after a single treatment of modified cancer-killing immune system cells. . . . → Read More: Engineered T-Cells Tested on Metastatic Cancer The transition team for president-elect Donald Trump is seeking details about activities of U.S. national labs and programs related to climate change operated by Department of Energy. . . . → Read More: Trump Transition Seeking Info on National Labs An enterprise formed earlier this year is licensing an engineered bone tissue repair technology that mixes ultrafine diamond particles with biocompatible polymers. . . . → Read More: Start-Up Developing Nanotech Bone Repairs Synthetic beta cells, like natural cells in the pancreas, were shown in tests with lab mice to sense glucose levels in the blood and produce insulin. . . . → Read More: Synthetic Insulin-Producing Cells Designed, Tested IBM is developing Watson super-computer and cloud computing applications with Rice University to create robot assistants that help older individuals remain safe in their own homes. . . . → Read More: IBM, Rice Univ. Partner on Elder Care Robots Pulsating LED lights were shown in lab mice to reduce amyloid-beta plaque deposits associated with Alzheimer’s disease on brain cells, with the lead researchers starting a company to commercialize the technology. . . . → Read More: LEDs Shown to Reduce Alzheimer’s Brain Plaques Two companies offering medical analytics aim to provide cancer specialists with individualized genomic analyses for their patients, and more access to clinical trials. . . . → Read More: NantHealth, TransMed Partner on Cancer Genomics A new enterprise, spun-off from the Gladstone Institutes in San Francisco, plans to regenerate heart muscle from other cells to treat heart failure. . . . → Read More: Start-Up Reprogramming Stem Cells to Treat Heart Failure A clinical trial is inviting individuals with Alzheimer’s disease to test a device that its designers claim can reverse cognitive impairment resulting from Alzheimer’s disease. . . . → Read More: Trial to Test Radio Waves to Treat Alzheimer’s |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |